Insulet had one patents in digitalization during Q2 2024. Insulet Corp’s patents focus on medicament delivery devices utilizing cost functions to determine dosages, with components for medicament cost and performance cost. The cost functions may scale asymmetrically for different dosage ranges, offering flexibility to tailor dosages to the user and improve delivery management. Additionally, a cost function with a zero medicament cost component for certain dosages is utilized, enhancing conformance to performance targets. GlobalData’s report on Insulet gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
Insulet had no grants in digitalization as a theme in Q2 2024.
Recent Patents
Application: Adaptable asymmetric medicament cost component in a control system for medicament delivery (Patent ID: US20240165328A1)
The patent filed by Insulet Corp. describes medicament delivery devices that utilize cost functions in their control systems to determine medicament dosages. These cost functions consist of a medicament cost component and a performance cost component, with the medicament cost component scaling asymmetrically for different ranges of inputs, providing flexibility to tailor the cost component to the user. By using a cost function with a medicament cost component of zero for candidate dosages below a reference dosage, the system can better manage medicament delivery and conform to performance targets effectively.
The patent claims detail a system that determines values of a cost function for candidate doses of a medicament affecting a user's glucose levels, with different calculations for medicament cost components in various subranges of doses. The system then selects a dose to be delivered based on the cost function values. Additionally, the patent outlines a medicament delivery system that uses different scaling for the medicament cost component above specific thresholds, allowing for tailored dosage selection based on the cost function values. These innovations aim to enhance medicament delivery management and user adherence to performance targets.
To know more about GlobalData’s detailed insights on Insulet, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
